Eleven major neuroscientific research projects related to “The Science of Perception Box” are being funded by the Tiny Blue Dot Foundation, each project receiving three consecutive...
Biotechnology company Lusaris Therapeutics – which has a lead programme focusing on DMT for treatment-resistant depression – has launched with its Series A financing of US$60...
Palo Santo has announced the closing of its USD$50m (~£134.10m) fund which will go towards a diverse portfolio of businesses developing innovative psychedelic medicines and therapies.